Cognition Retained Earnings from 2010 to 2024

CGTX Stock

USD 0.40 0.01 2.44%

Cognition Therapeutics Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings will likely drop to about -148.2 M in 2024. Retained Earnings is the cumulative amount of net income that Cognition Therapeutics retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2010-12-31

Previous Quarter

-141.2 M

Current Value

-148.2 M

Quarterly Volatility

32.2 M

Credit Downgrade

Yuan Drop

Covid

Check Cognition Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cognition Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 239.4 K, Interest Expense of 25.6 K or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.38. Cognition financial statements analysis is a perfect complement when working with Cognition Therapeutics Valuation or Volatility modules.

Check out the analysis of Cognition Therapeutics Correlation against competitors.

For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.

Latest Cognition Therapeutics' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Cognition Therapeutics over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Cognition Therapeutics' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cognition Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (141.19 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Cognition Retained Earnings Regression Statistics

	Arithmetic Mean	(76,630,163)
	Coefficient Of Variation	(42.08)
	Mean Deviation	25,642,906
	Median	(58,239,000)
	Standard Deviation	32,243,637
	Sample Variance	1039.7T
	Range	90M
	R-Value	(0.79)
	Mean Square Error	428.1T
	R-Squared	0.62
	Significance	0.0005
	Slope	(5,666,354)
	Total Sum of Squares	14555.1T

Cognition Retained Earnings History

	2024	-148.2 M
	2023	-141.2 M
	2022	-115.4 M
	2021	-94 M
	2020	-68.2 M

Other Fundumenentals of Cognition Therapeutics

Retained Earnings Total Equity

Cognition Therapeutics Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Surpluse	Short Long Term Debt
Total Assets		0.98	0.95	0.07	-1.0	-0.78	0.94	0.78	-0.52	-0.95	0.99	1.0	0.91	1.0	0.67	0.91	-0.84	-0.37	-0.38
Total Stockholder Equity	0.98		0.99	0.2	-0.99	-0.87	0.96	0.79	-0.55	-0.99	1.0	0.98	0.95	0.97	0.61	0.95	-0.83	-0.52	-0.52
Net Tangible Assets	0.95	0.99		0.26	-0.96	-0.92	0.96	0.8	-0.6	-1.0	0.99	0.95	0.96	0.93	0.6	0.96	-0.84	-0.62	-0.63
Current Deferred Revenue	0.07	0.2	0.26		-0.08	-0.4	0.11	-0.04	0.23	-0.29	0.18	0.05	0.35	0.01	-0.5	0.35	0.25	-0.38	-0.39
Net Debt	-1.0	-0.99	-0.96	-0.08		0.8	-0.96	-0.77	0.53	0.97	-0.99	-1.0	-0.91	-0.99	-0.65	-0.91	0.84	0.42	0.43
Retained Earnings	-0.78	-0.87	-0.92	-0.4	0.8		-0.8	-0.8	0.7	0.91	-0.87	-0.77	-0.91	-0.74	-0.55	-0.91	0.78	0.82	0.83
Accounts Payable	0.94	0.96	0.96	0.11	-0.96	-0.8		0.73	-0.55	-0.96	0.96	0.95	0.9	0.93	0.59	0.9	-0.82	-0.5	-0.51
Long Term Debt	0.78	0.79	0.8	-0.04	-0.77	-0.8	0.73		-0.88	-0.77	0.8	0.78	0.85	0.76	0.86	0.85	-0.88	-0.42	-0.44
Net Receivables	-0.52	-0.55	-0.6	0.23	0.53	0.7	-0.55	-0.88		0.56	-0.57	-0.53	-0.6	-0.5	-0.88	-0.6	0.86	0.57	0.58
Total Liab	-0.95	-0.99	-1.0	-0.29	0.97	0.91	-0.96	-0.77	0.56		-0.99	-0.95	-0.96	-0.93	-0.57	-0.96	0.81	0.6	0.61
Net Invested Capital	0.99	1.0	0.99	0.18	-0.99	-0.87	0.96	0.8	-0.57	-0.99		0.98	0.95	0.97	0.64	0.95	-0.85	-0.51	-0.52
Total Current Assets	1.0	0.98	0.95	0.05	-1.0	-0.77	0.95	0.78	-0.53	-0.95	0.98		0.91	1.0	0.67	0.91	-0.85	-0.37	-0.38
Capital Stock	0.91	0.95	0.96	0.35	-0.91	-0.91	0.9	0.85	-0.6	-0.96	0.95	0.91		0.88	0.56	1.0	-0.76	-0.52	-0.54
Net Working Capital	1.0	0.97	0.93	0.01	-0.99	-0.74	0.93	0.76	-0.5	-0.93	0.97	1.0	0.88		0.68	0.88	-0.84	-0.34	-0.34
Short Term Debt	0.67	0.61	0.6	-0.5	-0.65	-0.55	0.59	0.86	-0.88	-0.57	0.64	0.67	0.56	0.68		0.56	-0.92	-0.28	-0.28
Common Stock	0.91	0.95	0.96	0.35	-0.91	-0.91	0.9	0.85	-0.6	-0.96	0.95	0.91	1.0	0.88	0.56		-0.76	-0.52	-0.54
Property Plant Equipment	-0.84	-0.83	-0.84	0.25	0.84	0.78	-0.82	-0.88	0.86	0.81	-0.85	-0.85	-0.76	-0.84	-0.92	-0.76		0.54	0.54
Capital Surpluse	-0.37	-0.52	-0.62	-0.38	0.42	0.82	-0.5	-0.42	0.57	0.6	-0.51	-0.37	-0.52	-0.34	-0.28	-0.52	0.54		1.0
Short Long Term Debt	-0.38	-0.52	-0.63	-0.39	0.43	0.83	-0.51	-0.44	0.58	0.61	-0.52	-0.38	-0.54	-0.34	-0.28	-0.54	0.54	1.0

Click cells to compare fundamentals

About Cognition Therapeutics Financial Statements

Cognition Therapeutics investors use historical fundamental indicators, such as Cognition Therapeutics' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cognition Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-141.2 M	-148.2 M
Retained Earnings Total Equity	-103.9 M	-109.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC